Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. India
  4. Bombay Stock Exchange
  5. Torrent Pharmaceuticals Limited
  6. Summary
    500420   INE685A01028

TORRENT PHARMACEUTICALS LIMITED

(500420)
  Report
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Bombay Stock Exchange
09/20/2021 09/21/2021 09/22/2021 09/23/2021 09/24/2021 Date
3049 3043.1 3087.35 3102.2 3100.25 Last
1864 3725 1867 50729 378891 Volume
-1.53% -0.19% +1.45% +0.48% -0.06% Change
Estimated financial data (e)
Sales 2022 87 670 M 1 188 M 1 188 M
Net income 2022 13 099 M 177 M 177 M
Net Debt 2022 22 727 M 308 M 308 M
P/E ratio 2022 39,9x
Yield 2022 0,80%
Sales 2023 98 157 M 1 330 M 1 330 M
Net income 2023 15 869 M 215 M 215 M
Net Debt 2023 9 813 M 133 M 133 M
P/E ratio 2023 32,7x
Yield 2023 0,91%
Capitalization 525 B 7 108 M 7 108 M
EV / Sales 2022 6,24x
EV / Sales 2023 5,44x
Nbr of Employees 13 505
Free-Float 28,6%
More Financials
Company
Torrent Pharmaceuticals Limited is engaged in the manufacture and sale of branded, as well as unbranded generic pharmaceutical products. The Company operates in the therapeutic areas of cardiovascular (CV), central nervous system (CNS), gastrointestinal, diabetology, anti-infective, anti-diabetics and pain management segments. The Company offers products in various categories, including tablets, capsule and... 
Sector
Pharmaceuticals
Calendar
11/04Earnings Release
More about the company
Ratings of Torrent Pharmaceuticals Limited
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C+
More Ratings
All news about TORRENT PHARMACEUTICALS LIMITED
07/29TORRENT PHARMACEUTICALS : Nomura Adjusts Torrent Pharmaceuticals' Price Target to 3,345 In..
MT
07/28Torrent Pharmaceuticals Limited Approves Final Dividend for the Financial Year Ended Ma..
CI
07/28Torrent Pharmaceuticals Limited Approves Interim Dividend for the Financial Year Ended ..
CI
07/28Indian shares fall as banks and pharma drag; IMF cuts growth forecast
RE
07/28TORRENT PHARMACEUTICALS' : Consolidated Profit Climbs 3% in Fiscal Q1
MT
07/27Torrent Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended Ju..
CI
06/30MERCK : COVID-19 Antiviral Drug to Be Tested in India By Five Major Pharmaceuticals
MT
06/29MERCK : Five Indian Drugmakers to Begin Local Clinical Trial of Merck & Co.'s Experimental..
MT
06/29Five Indian drugmakers to jointly start local trial of Merck & Co's COVID-19 drug
RE
06/17TORRENT PHARMACEUTICALS LIMITED : Ex-dividend day for final dividend
FA
05/20TORRENT PHARMACEUTICALS : Nomura Adjusts Torrent Pharmaceuticals' Price Target to 3,062 In..
MT
05/19TORRENT PHARMACEUTICALS' : Board Proposes to Raise Nearly $684 Million Via Qualified Insti..
MT
05/18Torrent Pharmaceuticals Limited Recommends Final Dividend, Payable on or Around July 30..
CI
05/18Torrent Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter Ended M..
CI
05/13TORRENT PHARMACEUTICALS : Signs Licensing Agreement with Eli Lilly for COVID-19 Treatment ..
MT
More news
News in other languages on TORRENT PHARMACEUTICALS LIMITED

- No features available -

More news
Analyst Recommendations on TORRENT PHARMACEUTICALS LIMITED
More recommendations
Chart TORRENT PHARMACEUTICALS LIMITED
Duration : Period :
Torrent Pharmaceuticals Limited Technical Analysis Chart | 500420 | INE685A01028 | MarketScreener
Technical analysis trends TORRENT PHARMACEUTICALS LIMITED
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 24
Last Close Price 3 100,25 INR
Average target price 3 128,58 INR
Spread / Average Target 0,91%
EPS Revisions
Managers and Directors
Sudhir Menon Chief Financial Officer
Samir Uttamlal Mehta Executive Chairman
Jinesh Shah Director & Operations Director
Mahesh Agrawal Secretary, VP-Legal & Compliance Officer
Shailesh Vishnubhai Haribhakti Independent Non-Executive Director
Sector and Competitors
1st jan.Capi. (M$)
TORRENT PHARMACEUTICALS LIMITED10.70%7 108
JOHNSON & JOHNSON4.44%432 675
ROCHE HOLDING AG10.16%321 605
PFIZER, INC.20.05%246 358
NOVO NORDISK A/S50.45%231 485
ELI LILLY AND COMPANY37.22%210 037